Search Results - "STROHFELDT, K"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Substituted titanocenes induce caspase-dependent apoptosis in human epidermoid carcinoma cells in vitro and exhibit antitumour activity in vivo by BANNON, J. H, FICHTNER, I, O'NEILL, A, PAMPILLON, C, SWEENEY, N. J, STROHFELDT, K, WATSON, R. W, TACKE, M, MC GEE, M. M

    Published in British journal of cancer (05-11-2007)
    “…Titanocene compounds are a novel series of agents that exhibit cytotoxic effects in a variety of human cancer cells in vitro and in vivo. In this study, the…”
    Get full text
    Journal Article
  2. 2

    Novel titanocene anti-cancer drugs and their effect on apoptosis and the apoptotic pathway in prostate cancer cells by O'Connor, K, Gill, C, Tacke, M, Rehmann, F-J K, Strohfeldt, K, Sweeney, N, Fitzpatrick, J M, Watson, R W G

    Published in Apoptosis (London) (01-07-2006)
    “…Advanced prostate cancer is not curable by current treatment strategies indicating a significant need for new chemotherapeutic options. Highly substituted…”
    Get full text
    Journal Article
  3. 3

    3-Silaoxetane and 3-silathietane: structure and reactivity studies on the basis of spectroscopic data and theoretical calculations by Pavel, I., Strohfeldt, K., Strohmann, C., Kiefer, W.

    Published in Inorganica Chimica Acta (20-04-2004)
    “…Raman spectra were obtained from 3-silaoxetane 3,3-dimethyl-2,2,4,4-tetraphenyl-1-oxa-3-silacyclobutane ( 1) and 3-silathietane…”
    Get full text
    Journal Article
  4. 4

    Novel benzyl substituted titanocene anti-cancer drugs by Sweeney, Nigel J., Mendoza, Oscar, Müller-Bunz, Helge, Pampillón, Clara, Rehmann, Franz-Josef K., Strohfeldt, Katja, Tacke, Matthias

    Published in Journal of organometallic chemistry (01-11-2005)
    “…Bis-[( p-methoxybenzyl)cyclopentadienyl]titanium (IV) dichloride is a promising candidate for an anti-cancer drug and was synthesised starting from 6-(…”
    Get full text
    Journal Article
  5. 5

    The Crystal Structures of the Chiral Alkyllithium Bases [n-BuLi·(−)-Sparteine]2 and [Et2O·(i-PrLi)2·(−)-Sparteine] by Strohmann, Carsten, Strohfeldt, Katja, Schildbach, Daniel

    Published in Journal of the American Chemical Society (12-11-2003)
    “…The crystal structures of the two chiral alkyllithium bases [n-BuLi·(−)-sparteine]2 (1) and [Et2O·(i-PrLi)2·(−)-sparteine] (2) have been determined. For…”
    Get full text
    Journal Article
  6. 6

    [tBuLi⋅(−)-Sparteine]: Molecular Structure of the First Monomeric Butyllithium Compound by Strohmann, Carsten, Seibel, Timo, Strohfeldt, Katja

    Published in Angewandte Chemie International Edition (29-09-2003)
    “…A chiral butyllithium reagent: Monomeric [tBuLi⋅(−)‐sparteine] crystallizes from a solution in n‐pentane on cooling. At the lithium center of the compound a…”
    Get full text
    Journal Article
  7. 7

    In-vitro anti-tumor activity studies of bridged and unbridged benzyl-substituted titanocenes by Kelter, Gerhard, Sweeney, Nigel J, Strohfeldt, Katja, Fiebig, Heinz-Herbert, Tacke, Matthias

    Published in Anti-cancer drugs (01-11-2005)
    “…The benzyl-substituted ansa-titanocenes [1,2-di(cyclopentadienyl)-1,2-di-(4-N,N-dimethylaminophenyl)ethanediyl] titanium dichloride (Titanocene X) and…”
    Get full text
    Journal Article
  8. 8

    Crystal Structures of (+)-Sparteine Surrogate Adducts of Methyllithium and Phenyllithium by Strohmann, Carsten, Strohfeldt, Katja, Schildbach, Daniel, McGrath, Matthew J, O'Brien, Peter

    Published in Organometallics (08-11-2004)
    “…The crystal structures of aggregates between MeLi and PhLi and a (+)-sparteine surrogate ((+)-2) have been determined. The MeLi adduct 4 reveals a 2:2 dimer,…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Heteroaryl substituted ansa-titanocene anti-cancer drugs derived from fulvenes and titanium dichloride by Rehmann, Franz-Josef K., Cuffe, Laurence P., Mendoza, Oscar, Rai, Dilip K., Sweeney, Nigel, Strohfeldt, Katja, Gallagher, William M., Tacke, Matthias

    Published in Applied organometallic chemistry (01-03-2005)
    “…Starting from 2‐furylfulvene (1a), 2‐thiophenylfulvene (1b), and 1‐methyl‐2‐pyrrolylfulvene (1c), [1,2‐di(cyclopentadienyl)‐1,2‐di‐(2‐furyl)ethanediyl]…”
    Get full text
    Journal Article
  11. 11

    Activity of [1,2-di(cyclopentadienyl)-1,2-di(p-N,N-dimethylaminophenyl)-ethanediyl] titanium dichloride against tumor colony-forming units by Oberschmidt, Olaf, Hanauske, Axel-R, Rehmann, Franz-Josef K, Strohfeldt, Katja, Sweeney, Nigel, Tacke, Matthias

    Published in Anti-cancer drugs (01-11-2005)
    “…[1,2-di(cyclopentadienyl)-1,2-di(p-N,N-dimethylaminophenyl)-ethanediyl] titanium dichloride is a newly synthesized transition metal-based anti-cancer drug. We…”
    Get full text
    Journal Article
  12. 12
  13. 13

    A trimethoxyphenyl substituted ansa-titanocene: A possible anti-cancer drug by Rehmann, Franz-Josef K., Rous, Andrew J., Mendoza, Oscar, Sweeney, Nigel J., Strohfeldt, Katja, Gallagher, William M., Tacke, Matthias

    Published in Polyhedron (04-08-2005)
    “…The water soluble ansa-titanocene [1,2-di(cyclopentadienyl)-1,2-di-(3′,4′,5′-trimethoxyphenyl)-ethanediyl] titanium dichloride is a possible anti-cancer drug…”
    Get full text
    Journal Article